The rising popularity in GLP-1 agonists for diabetes has generated a discussion about delivery routes : skin-applied devices versus tablets . Typically, GLP-1 therapies were only available in oral form, https://cecilyzfqf768553.blogerus.com/62922344/glp-1-transdermal-delivery-systems-vs-oral-medications-which-best-for-individuals